EugenePascholdMD

PubMed

• 178 citations
  A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer
  Mark A. Socinski, Jonathan H. Goldman, Iman El-Hariry, Marianna Koczywas, V. Vukovic, Leora Horn, Eugene Paschold, Ravi Salgia, Howard West, Lecia V. Sequist, Philip B...> ;Clinical Cancer Research. 2013 Jun 1
• An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).
  Wong K, Koczywas M, Goldman JW, Paschold EH, Horn L, Lufkin JM, Blackman RK, Teofilovici F, Shapiro G, Socinski MA> ;J. Clin. Oncol.. 2011-05-20
• Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).
  Jotte R, Von Pawel J, Spigel DR, Socinski MA, O'Brien M, Paschold EH, Mezger J, Steins M, Bosquée L, Bubis JA, Nackaerts K, Trigo Perez JM, Clingan PR, Schuette W, Lor...> ;J. Clin. Oncol.. 2011-05-20
• 337 citations
  Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099
  Thomas J. Lynch, Taral Patel, Luke Dreisbach, Michael McCleod, William J. Heim, Robert C. Hermann, Eugene Henry Paschold, Nicholas Iannotti, Shaker R. Dakhil, Steven G...> ;Journal of Clinical Oncology. 2010 Feb 20
• 6 citations
  Results of a Phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer
  Marcus A. Neubauer, Ralph Heaven, Jairo Olivares, Alvin Otsuka, Eugene Paschold, Christopher Sirridge, Des Ilegbodu, Troy Tuttle, Lina Asmar> ;Lung Cancer. 2004 Dec 1
• 11 citations
  Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
  James T. Thompson, Eugene H. Paschold, Edward A. Levine> ;The American Surgeon. 2001 Jun 1
• 58 citations
  Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
  Hyman B. Muss, Wells Hb, Eugene H. Paschold, W R Black, Cooper Mr, Robert L. Capizzi, Richard M. Christian, Julia M. Cruz, Don V. Jackson, Bayard L. Powell> ;Journal of Clinical Oncology. 1988 Jul 1
• Megestrol acetate as primary hormonal therapy for advanced breast cancer.
  Johnson PA, Muss H, Bonomi P, Von Roenn J, Wolter J, Paschold E, Black W, Cooper M> ;Semin. Oncol.. 1988-04-01
• 38 citations
  Clinical trial of pyridoxine to reduce vincristine neurotoxicity
  Don V. Jackson, E K Pope, R. A. Mcmahan, M. Robert Cooper, James N. Atkins, Richard D. Callahan, Eugene H. Paschold, Ruby A. Grimm, Judith O. Hopkins, Hyman B. Muss, F...> ;Journal of Neuro-Oncology. 1986 Jan 1
• Arterial thromboembolic complications of peritoneovenous shunting for malignant ascites
  Eugene H. Paschold, Don V. Jackson, David A. Albertson, Ralph D. Woodruff> ;Journal of Surgical Oncology. 1984 Oct 1
• 31 citations
  Treatment of advanced non-Hodgkin's lymphoma with vincristine infusion
  Don V. Jackson, Eugene H. Paschold, Charles L. Spurr, Hyman B. Muss, Frederick Richards, M. Robert Cooper, Douglas R. White, John J. Stuart, Judith O. Hopkins, Robert ...> ;Cancer. 1984 Jun 15
• Current concepts in the management of breast cancer.
  Paschold, E. H., Muss, H. B.> ;Am Fam Physician. 1981 Sep
• Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA).
  Muss, H. B., Paschold, E. H., Black, W. R., Cooper, M. R., Capizzi, R. L., Christian, R., Cruz, J. M., Jackson, D. V., Stuart, J. J., Richards, F.> ;Semin Oncol. 1985 Mar 01
• Join now to see all